Abionic has appointed Gerd Grenner and Nader Donzel to its board of directors.
Grenner has more than 35 years’ experience in R&D management positions in medical diagnostics companies. He previously held several top management positions at Roche Diagnostics in Basel, Switzerland, including chief scientific officer, chief technology officer, and director of global R&D.
Since 2014, Donzel has been the general manager of Scitec Research, a private laboratory offering chemical analytical services. Before Scitec, he was co-founder and held several executive positions at Biocartis.